Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Clin Trials. 2019 Oct 24;17(1):3–14. doi: 10.1177/1740774519881616

Table 5.

Secondary endpoints of the Monitoring Substudy

On-site No on-site OR (95% CI)a p-valuea
No. sites 99 97
No. participants 2107 2264
Pct. lost to follow-upb 7.1 8.6 0.8 (0.5, 1.1) 0.19
 - withdrawal due to site closure 0.4 1.1
 - withdrawal of consent 2.3 2.4
 - no data for 10 months 4.4 5.0
No. follow-up visits expectedc 30237 32585
 Pct. of visits missed 8.6 7.8
No. follow-up visits attended 27629 30035
 Pct. forms submitted > 2 weeks after visit 29.2 23.0
 Pct. forms with query upon submission 38.7 31.2
 Pct. forms clean > 2 weeks 20.9 15.7
 Pct. forms with missing required data 8.4 5.9
a

Logistic regression fixed effects hierarchical model comparing the on-site group to the no on-site group

b

No data in 10 months or withdrawal from START after the opening of the monitoring substudy

c

Baseline and START follow-up visits that took place or whose visit window closed between 1 Sep 2011 and 31 Dec 2016